drugset / Trial / NCT02733471

Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy

NCT02733471 ↗

Phase 4 Completed 586 enrolled Basque Health Service
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the efficacy and safety of the administration of lidocaine spray in oesophago-gastro-duodenoscopies. Half of the patients will receive lidocaine spray, while the other half will receive a placebo.

Timeline

Start
2016-04
Primary completion
2017-04
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 50 mg Topical

Indications

No indication recorded.